GlassScriptPhysician profile
Anand Badri
NPI 1679951180
$8,455.32
in general payments reported to CMS, 2019-2025
43 companies · $2,927 in 2025
The $2,927 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.69 · 2021: $118 · 2022: $303 · 2023: $1,808 · 2024: $3,271 · 2025: $2,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,042 · Travel and Lodging: $769 · Education: $168 · Entertainment: $18.59 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,042.29 |
| Travel and Lodging | $769.19 |
| Education | $167.99 |
| Entertainment | $18.59 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,365.43 | 2022-2025 | Erleada, Akeega |
| Intuitive Surgical, INC. | $1,149.91 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,062.26 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $849.46 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $526.60 | 2022-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $391.39 | 2023-2025 | Provenge |
| Boston Scientific Corporation | $257.64 | 2021-2025 | Lithovue, Axonics, Ams 700 |
| Pfizer INC. | $241.93 | 2022-2025 | |
| Teleflex LLC | $219.81 | 2021-2025 | Urolift, Barrigel |
| Novartis Pharmaceuticals Corporation | $215.36 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $204.49 | 2022-2025 | Pylarify |
| Merck Sharp & Dohme LLC | $178.98 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Urogen Pharma, INC. | $173.36 | 2023-2025 | Jelmyto |
| Immunitybio, INC. | $157.57 | 2024-2025 | |
| Civco Medical Instruments | $137.05 | 2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $122.60 | 2024-2025 | Xiaflex |
| Tolmar, INC. | $107.67 | 2023-2025 | Eligard, Jatenzo |
| Astellas Pharma Global Development | $86.40 | 2025 | Xtandi |
| Abbvie INC. | $79.54 | 2024 | |
| 180 Medical, INC. | $79.45 | 2021-2022 | |
| Dentsply Ih Ab | $75.27 | 2023 | Lofric |
| Calyxo, INC. | $68.09 | 2025 | Cvac Aspiration System |
| Pacira Pharmaceuticals Incorporated | $54.41 | 2024 | Exparel |
| Endo Pharmaceuticals INC. | $51.38 | 2023-2024 | Xiaflex |
| Ferring Pharmaceuticals INC. | $51.29 | 2024-2025 | Adstiladrin |
| Blue Earth Diagnostics | $50.51 | 2023-2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $50.02 | 2023-2024 | Prolaris |
| Urovant Sciences INC | $43.64 | 2022 | |
| Bluewind Medical | $37.63 | 2024 | Revi |
| Palette Life Sciences, INC. | $37.20 | 2023 | |
| Myovant Sciences INC. | $35.59 | 2022 | |
| Telix Pharmaceuticals | $35.38 | 2024 | Illuccix |
| Sun Pharmaceutical Industries INC. | $31.30 | 2023 | Yonsa |
| Olympus America INC. | $27.61 | 2025 | Itind System |
| Profound Medical Corp. | $25.67 | 2025 | Tulsa-Pro |
| Fennec Pharmaceuticals, INC. | $24.64 | 2024 | Pedmark |
| Janssen Scientific Affairs, LLC | $24.62 | 2025 | Erleada |
| Axonics, INC. | $23.20 | 2023 | Axonics |
| Mimedx Group, INC. | $22.42 | 2025 | |
| Mission Pharmacal Company | $20.72 | 2024 | Uribel Tabs |
| Antares Pharma, INC. | $19.68 | 2025 | Xyosted |
| Procept Biorobotics Corporation | $19.56 | 2024 | Aquabeam System |
| Provepharm INC. | $18.59 | 2024 | Bludigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Badri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.